At the top and at the heart of the life science ecosystem™
NEW YORK, June 22, 2022 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE), a city office REIT and the first, longest-serving and pioneering owner, operator and developer to uniquely focus on collaborative life science, Agtech and Technology Campus in AAA Innovation Concentrates Cluster Sites, Celebrates Alexandria LaunchLabs Grand Opening Today® at Columbia, which was created in strategic collaboration with University of Columbia. As the company’s second LaunchLabs location in NYCAlexandria LaunchLabs in Columbia builds on the success of the flagship LaunchLabs location at the Alexandria Center® for Life Sciences – NYC, which celebrated its fifth anniversary this month. The grand inaugural event marks a major milestone for the unique and leading life science startup platform, specifically designed to accelerate innovation and growth for promising early-stage companies. With over 10,000 diseases known to man, less than 10% of which are currently treatable with therapies, Alexandria LaunchLabs in Columbia plays an integral role in accelerating the translation of the scientific research that results University of Columbia and other leading academic and medical research institutions in New York for treatments and cures to meet humanity’s tremendous unmet medical needs and alleviate the suffering of patients.
“For years there has been an explosion of new startup creations emerging from it Colombia’s research labs (25+ new startups per year) as well as from the labs at our other research facilities in NYC,” said Orin Herskowitz, Managing Director of Columbia Technology Ventures. “The integration of the Alexandria LaunchLabs platform in Colombia’s Campus provides another boost to NYC’s entrepreneurial ecosystem, Colombia’s Startups, other NYC Startups and the city as a whole. We couldn’t be happier to have the Alexandria LaunchLabs platform on campus.”
Alexandria spearheaded the creation of NYC’s commercial life science cluster through the development of the Alexandria Center for Life Science, the city’s first and only commercial life science campus. Since opening this flagship campus in 2010 Alexandria has successfully led, catalyzed and nurtured a collaborative ecosystem that brings together translational innovation, leading scientific and management talent and sophisticated capital with world-renowned academic and medical institutions to advance the discovery, development and commercialization of breakthrough therapies and cures that are being expanded, improved and improved can save patient lives. By leveraging its position as a leader and partner in the life science ecosystem, the company has been instrumental in the success of many of the city’s most promising life science companies. Intracellular therapies approved by the FDA for the treatment of adult bipolar depression and schizophrenia are a prime example of one Alexandria Tenant who took scientific knowledge from the bank and successfully applied it to enable the delivery of novel medicines to patients around the world suffering from these intractable central nervous system disorders.
“We are very proud to be leaders and pioneers in catalyzing, growing and developing NYC commercial life science ecosystem and cluster, where we have increased the value of our mission-critical laboratory properties through our strategic venture activities and advisory, thought leadership and ecosystem-building programs, and our innovative proprietary offerings such as LaunchLabs,” said Joel S Marcus, Chairman and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. “The embedding of our proven LaunchLabs platform under Columbia is critical to advancing transformative medicines for the benefit of society, and we are honored to expand our long-standing relationship Columbiaan extraordinary institution that has made a rich contribution to human health in this mission-critical and worthwhile endeavor.”
“As LaunchLabs celebrates its one year anniversary Columbia“We have carefully curated an outstanding group of member companies from across the local ecosystem, utilizing novel therapeutic and diagnostic platforms to treat a wide range of diseases, including difficult-to-treat cancers, neurodegenerative and autoimmune diseases, as well as metabolic and rare genetic diseases,” said Michael NordsenDirector of Science and Technology at Alexandria Venture Investments and Head of Alexandria LaunchLabs Columbia for Alexandria Real Estate Equities, Inc. “The opportunity to strategically expand our LaunchLabs platform in collaboration with Columbia enhances our ability to empower life science entrepreneurship, nurture the city’s most promising biotech startups, and continue to attract and retain top talent in the local NYC ecosystem.”
In addition to its grand opening event at the Alexandria LaunchLabs Columbiatoday Alexandria convenes its annual New York City Life Science Innovation Showcase at the Alexandria Center for Life Science – NYC. This showcase celebrates a curated group of outstanding life science entrepreneurs and startups from New York’s top academic and medical research institutions. The program will feature fast-paced company presentations interspersed with panel discussions featuring some of the city’s most notable founders, executives and venture investors, all with a common goal of accelerating the translation of novel discoveries into biomedical realities to address many of the most challenging diseases known to man.
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® urban office REIT, is the first, longest-serving and pioneering owner, operator and developer with a unique focus on collaborative life science, agtech and technology campuses in AAA innovation cluster locations and has an asset base in North America from 74.2 million SF March 31, 2022. The asset base in North America includes RSF 41.9 million in operating properties and RSF 5.4 million in Class A properties under construction, RSF 10.4 million in short- and medium-term development and rehabilitation projects, and SF 16.5 million in future developments. founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations including Greater Bostonthe Bay area of San Francisco, NYC, San Diego, Seattle, Maryland and research triangle. Alexandria has a long and proven track record of developing Class A properties located in urban life science, agtech and technology campuses that offer our innovative tenants highly dynamic and collaborative environments that enhance their ability to be world class -Successfully recruit and retain talent and inspire productivity, efficiency, creativity and success. Alexandria also provides strategic capital to transformative life science, agtech and technology companies through our venture capital platform. We believe our unique business model and careful underwriting ensure a high quality and diverse tenant base that translates into higher occupancy, longer lease terms, higher rental income, higher returns and greater long-term asset value. More information about Alexandriaplease visit www.are.com.
About Alexandria LaunchLabs
Alexandria LaunchLabs, founded by the pioneer of mission-critical labspace® Real Estate, is the leading life science startup platform purpose-built to accelerate the growth of transformative early-stage businesses and enable the advancement of groundbreaking discoveries Alexandria thriving life science ecosystems in NYC, Cambridgeresearch triangle, Seattle and Stanford Research Park. Alexandria LaunchLabs is unmatched in providing early-stage life science companies with dedicated lab/office space and core equipment, key operational services, curated introductions to our world-class network, access to capital through Alexandria Venture Investments and the Alexandria Seed Capital Platform, and expert support by our world-class teams – all built to provide a scalable growth path for our curated community of member companies. Alexandria LaunchLabs is currently accepting applications for all locations. For more information, please visit www.alexandrialaunchlabs.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding the potential impact of Alexandria LaunchLabs on University of Columbia on Alexandria and its tenants’ businesses, continued growth, goals and ability to attract and retain talent, and the impact on the broader life sciences industry. These forward-looking statements are based on the Company’s current intentions, beliefs or expectations, but the occurrence of any forward-looking statements is not guaranteed and may not occur. Actual results could differ materially from those expressed or implied by the Company’s forward-looking statements due to a variety of factors, including, but not limited to, the risks and uncertainties discussed in its filings with the Securities and Exchange Commission. All forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update this information. For more information on risks and uncertainties that could cause actual results to differ materially from those anticipated in the Company’s forward-looking statements and risks and uncertainties related to the Company’s business generally, please refer to the Company’s filings at the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.
CONTACT: Sara KabakoffVice President – Communications, (626) 788-5578, [email protected]
SOURCE Alexandria Real Estate Equities, Inc.